Atul Dandekar serves as Executive at Maze Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Atul Dandekar has executed 5 insider transactions totaling $2.9M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 30, 2025 involved selling 100 shares valued at $4.0K.
Atul Dandekar currently holds 10,503 shares of Maze Therapeutics, Inc. (MAZE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Atul Dandekar has been a net seller of MAZE stock. They have purchased $0 and sold $2.9M worth of shares.
Atul Dandekar's most recent insider trade was on Dec 30, 2025, when they sold 100 shares at $40.36 per share.
Get notified when new Form 4 filings are submitted
| $10.42 |
| Discretionary |
| Dec 29, 2025 | MAZE | $754.4K | Option Exercise | 72,400 | $10.42 | Discretionary |
| Dec 29, 2025 | MAZE | $2.7M | Sale | 66,365 | $40.51 | Discretionary |
| Dec 29, 2025 | MAZE | $248.2K | Sale | 6,035 | $41.13 | Discretionary |